Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation

Bone Marrow Transplantation
Y KishimotoS Fukuhara

Abstract

We report an unusual case of a patient who was cured of one autoimmune disease (palmoplantar pustular psoriasis (PPP)) but developed another autoimmune disease (autoimmune thyroiditis) after allogeneic BMT. A 40-year-old man suffering from AML with PPP underwent allogeneic BMT from his HLA-identical sister for the treatment of AML. The patient experienced complete clearance of the cutaneous PPP despite the cessation of immunosuppressive therapy for over 2 years. However, he developed hyperthyroidism with anti-thyroglobulin antibodies 5 months after BMT, although he had showed normal thyroid functions without anti-thyroglobulin antibodies before BMT. The donor had no history of thyroid diseases and showed normal thyroid functions but was positive for anti-thyroglobulin antibodies. Thus, even when the donor is in a subclinical state, autoimmune thyroiditis may be transferred from donors to recipients by BMT.

Citations

Mar 20, 1998·Arthritis and Rheumatism·J A SnowdenJ C Biggs
Nov 15, 2002·International Journal of Hematology·Richard K BurtAlberto M Marmont
May 29, 2008·Immunologic Research·Nagwa S El-BadriRobert A Good
Jun 29, 2004·La Revue de médecine interne·S VinzioB Goichot
Aug 10, 1999·Critical Reviews in Oncology/hematology·A Gratwohl, A Tyndall
Nov 5, 1999·Current Opinion in Hematology·J PasswegA Tyndall
Jul 31, 2004·Journal of Pediatric Hematology/oncology·Ruth TatevossianAnanth Gouri Shankar
Jun 15, 2006·Journal of Pediatric Hematology/oncology·Vincent LeeChi Kong Li
Nov 26, 2010·Immunotherapy·Rebecca Manno, Francesco Boin
Sep 18, 2012·Journal of the American Academy of Dermatology·Benjamin H KaffenbergerLeslie A Andritsos
Apr 24, 2007·Best Practice & Research. Clinical Haematology·Thomas Daikeler, Alan Tyndall
Feb 3, 2005·British Journal of Haematology·R E HoughN M Wulffraat
Mar 26, 2003·Histopathology·M R Canninga-van DijkJ G van den Tweel
Jan 22, 2005·Neurologic Clinics·Harold Atkins, Mark Freedman
May 30, 2006·The British Journal of Dermatology·S WahieS J Meggit
Jun 19, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Weiguo SuiYong Dai
Jul 10, 2003·Cytotherapy·P Scheinberg
Jan 27, 2017·International Journal of Molecular Sciences·Tae-Hoon ShinKyung-Sun Kang
Sep 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fadi BraitehRoy Jones
Oct 21, 2017·International Journal of Molecular Sciences·Agnieszka Owczarczyk-SaczonekJoanna Wojtkiewicz
Jan 11, 2005·Bone Marrow Transplantation·W Y AuY L Kwong
Nov 18, 2000·Bone Marrow Transplantation·S LeeS Ikehara
Jun 29, 2000·Oncogene·A FollenziP M Comoglio
May 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Haiyan S LiMehmet L Guler
Mar 30, 2021·Transplantation and Cellular Therapy·Iman ShifaJan Storek
May 27, 2021·The British Journal of Dermatology·S M LwinC E M Griffiths

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Autoimmune Thyroiditis

Autoimmune thyroiditis is an inflammatory disease of thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-cells and thyroid autoantibodies. Discover the latest research on autoimmune thyroiditis here.